CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-27 | Leoni Mollie Chief Medical Officer | Sale | −1,341 | $8.46 | $11K | 267,274 |
| 2026-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −2,226 | $8.46 | $19K | 150,083 |
| 2026-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −1,114 | $8.46 | $9K | 148,969 |
| 2026-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −695 | $8.46 | $6K | 148,274 |
| 2026-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −2,226 | $8.46 | $19K | 146,048 |
| 2026-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −881 | $8.46 | $7K | 145,167 |
| 2026-01-27 | Bair Teresa Brophy Chief Legal Officer | Sale | −4,096 | $8.46 | $35K | 234,043 |
| 2026-01-27 | Bair Teresa Brophy Chief Legal Officer | Sale | −2,335 | $8.46 | $20K | 231,708 |
| 2026-01-27 | Bair Teresa Brophy Chief Legal Officer | Sale | −4,777 | $8.46 | $40K | 226,931 |
| 2026-01-02 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +1,120,000 | 1,120,000 | ||
| 2026-01-02 | Leoni Mollie Chief Medical Officer | Grant or award | +50,000 | 275,454 | ||
| 2026-01-02 | Leoni Mollie Chief Medical Officer | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2026-01-02 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award | +21,250 | 152,309 | ||
| 2026-01-02 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award · Option to purchase common stock | +42,500 | 42,500 | ||
| 2026-01-02 | FORD KATHLEEN Chief Operating Officer | Grant or award | +50,000 | 155,373 | ||
| 2026-01-02 | FORD KATHLEEN Chief Operating Officer | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2026-01-02 | Burrows Francis Chief Scientific Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2026-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award | +50,000 | 189,689 | ||
| 2026-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2026-01-02 | Bair Teresa Brophy Chief Legal Officer | Grant or award | +50,000 | 238,139 |
Page 3 of 9 · 164 trades